(financialwire.net via COMTEX News Network) --

December 1, 2006 (FinancialWire) MIV Therapeutics Inc (OTCBB: MIVT) gained 42.11% Thursday on volume of 1,501,577, which was more than ten times its three-month average 142,869, to end the day at $0.54.

Companies in the sector include Medtronic Inc. (NYSE: MDT), Boston Scientific Corp. (NYSE: BSX), and Johnson & Johnson (NYSE: JNJ).

MIV Therapeutics was enrolled in Investrend Research affiliate SISM Research's professional analyst program. Complete information is available at the company's InvestorPower page, which is accessible from http://www.investrend.com/company/list.asp?sPathParam=yes .

For up-to-the-minute news, features and links click on http://www.FinancialWire.net

FinancialWire is an independent, proprietary news service of Investrend Information, a division of Investrend Communications, Inc. It is not a press release service and receives no compensation from any company for its news or opinions. Other divisions of Investrend, however, provide shareholder empowerment platforms such as forums, independent research and webcasting. For more information or to receive the FirstAlert daily summary of news, commentary, research reports, webcasts, events and conference calls, click on http://www.investrend.com/contact.asp

For a free annual report on a company mentioned in the news, please click on http://investrend.ar.wilink.com/?level=279

To become an investor monitor of independent research for a company in which you are invested, go to the not-for-profit Shareholders Research Alliance, Inc. website by clicking on http://www.shareholdersresearch.com/

The FinancialWire NewsFeed is now available in multiple formats to your site or desktop, free. Click on: http://www.investrend.com/XmlFeeds?level=268

http://www.financialwire.net